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Abstract
Emergency blood transfusion (EBT) is a life-saving intervention which also carries a 
significant risk of harm in the event of a transfusion reaction. Our chapter starts with a 
hypothetical case study of a gynecology patient who underwent emergent hysterectomy 
with severe hemorrhage managed with an emergency blood transfusion. During the 
aggressive resuscitation, the patient was inadvertently transfused with blood products 
that had been allocated for another patient. Through this clinical vignette, we review 
the operational aspects of an EBT and identify sources of transfusion-related errors. We 
emphasize best practices that can be implemented with the goal of improved patient 
safety. This chapter offers a concise, practical review of EBT for our readers.
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1. Introduction
Transfusion medicine is used to manage the bleeding patient. An emergency blood transfu-
sion (EBT) protocol describes how a massive blood transfusion (MBT) can be performed in an 
effort to compensate for the blood loss of a severe hemorrhage. Not every EBT is an MBT: in 
a patient with a low cardiopulmonary reserve, moderate blood loss can require an EBT but 
not the volume of an MBT. Near miss and sentinel events in the hospital setting continue to 
represent a significant concern for patient safety [1]. In the context of blood transfusions, a 
“near miss” event includes any error that could cause administration of an incorrect blood 
product but is recognized prior to the start of transfusion. Failure to recognize the error can 
result in the sentinel event of acute hemolytic transfusion reaction (AHTR) due to major blood 
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group incompatibility [2]. AHTR was a leading cause of transfusion-related mortality from 
2005 to 2009, second only to transfusion-related acute lung injury (TRALI) [3].
The blood administration process is challenging in a chaotic, often time-sensitive environ-
ment that employs high-volume blood transfusions to prevent a hemorrhaging patient from 
dying. This combination of factors creates a formidable risk to patient safety [1]. Optimal 
strategies have been developed to standardize the management of blood transfusions in the 
setting of a severe hemorrhage, irrespective of its etiology.
This chapter describes select best practices and identifies system vulnerabilities that may lead 
to near misses and sentinel events so as to improve patient outcomes and provide an error-
free delivery of blood products. We also review potential solutions that our institution has 
implemented to decrease the transfusion error risk associated with blood product administra-
tion. The case review subsequently underscores how imperative it is to identify the critical 
steps within the process of blood transfusions so as to prevent error.
2. A case review
A 48-year-old female presented to the emergency room of a busy community hospital with the 
chief complaint of a syncopal episode. She had a history of heavy menstrual bleeding caused by 
multiple uterine fibroids. Upon arrival, the patient was actively bleeding per vagina. She was pale, 
but alert and oriented, was tachycardia at 120 beats per minute, and had orthostatic hypotension.
Her past medical history was significant for a DVT while using combined oral contraceptive 
pills approximately 20 years before. Her past surgical history included a laparoscopic bilat-
eral tubal ligation. She was scheduled to undergo a hysterectomy later that month secondary 
to her history of heavy menses and her contraindication to estrogen therapy.
While being evaluated in the emergency room, her initial blood work demonstrated a hemo-
globin of 9 g/dL, down from her baseline of 12.5 g/dL. Her gynecologist was consulted who 
recommended performing the hysterectomy in the acute setting given her ongoing bleeding 
and contraindication to medical management. The patient agreed and consented for surgery.
On the same day, there was a second patient being admitted for a hysterectomy for endo-
metriosis. The patient was known to have two atypical blood antibodies necessitating 
cross-matched blood to be prepared. The operating staff and blood bank were in close com-
munication for this patient in an event of a hemorrhage.
The first patient was taken to the operating room where a total laparoscopic hysterectomy was 
performed. Secondary to the location of her uterine fibroids, the patient sustained a laceration 
to her right uterine artery upon manipulation of the uterus to better visualize the uterine ves-
sels. During attempts to control this bleeding, a massive blood transfusion (MBT) was initiated 
using non-cross-matched O negative blood. The gynecologic surgeons were unable to properly 
visualize and control the source of bleeding and therefore converted to a laparotomy.
Upon arrival of the blood products, the patient was immediately transfused. The surgeons com-
pleted the hysterectomy but continued to observe significant and diffuse pelvic bleeding. At this 
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time, a surgeon noted that the blood being transfused was not O negative blood. The anesthe-
siologist was alerted and he immediately stopped the transfusion. The circulating nurse called 
the blood bank to notify them of the error. The blood bank personnel had incorrectly assumed 
that the MBT was initiated for the patient who had tested positive for the antibodies. The operat-
ing room staff removed all blood products from the operating room, and new O negative non-
cross-matched blood was sent. By this time, the patient had developed a state of disseminated 
intravascular coagulation (DIC). With no identifiable active bleeding source, the patient’s pelvic 
cavity and vagina were packed, and she was transferred to the intensive care unit (ICU).
The patient’s ICU course included aggressive resuscitative efforts with multiple blood trans-
fusions and ventilator support due to transfusion-related acute lung injury (TRALI). Once 
stable, the patient was taken back to the operating room for removal of packing and re-explo-
ration where no active bleeding was noted. Fortunately, the patient recovered from her near-
fatal injuries, and she was eventually discharged home with a close outpatient follow-up.
3. Discussion
Hysterectomy is one of the most commonly performed surgical procedures in the United 
States. Symptomatic uterine fibroids are the leading indication for the procedure, accounting 
for 52% of this procedure. Abnormal uterine bleeding is the indication for another 42% of 
hysterectomies [4].
Similarly, maternal hemorrhage is a leading cause of maternal morbidity and mortality world-
wide. Its incidence varies widely but is thought to occur in 1–5% of all deliveries [5, 6]. This 
is a concerning fact since obstetric services are provided in 92% of rural hospitals [7]. These 
smaller hospitals do not have the same resources as their larger urban counterparts to handle 
severe hemorrhage from a variety of etiologies. For these smaller institutions, developing 
a standardized plan to manage emergencies such as postpartum hemorrhage is critical [7]. 
All surgical and emergency services should devise comprehensive approaches that identify, 
evaluate, treat, and monitor a hemorrhaging patient in order to stop bleeding at earlier stages, 
reduce the number of blood products transfused, and to reduce adverse outcomes [1]. The 
case review above demonstrates the need for an institution to establish and practice sound 
policies for the emergency preparation, transportation, and administration of blood products.
Root cause analysis (RCA) is a process with the primary aim of identifying any factors that 
may influence the nature, magnitude, timing, and/or occurrence of an error, keeping in mind 
that more than one root cause can impact an event. Through such a methodical approach, 
RCA is commonly employed after an occurrence of an error in order to develop and imple-
ment preventative strategies to improve future response and outcomes. Through this chapter, 
we perform a root cause analysis to systematically identify “root causes” of potential errors in 
the blood transfusion process.
Medical errors fall into one of two broad classes, errors of omission and errors of commission. 
An error of omission is one that occurs because an action was not taken, whereas an error of 
commission occurs because an incorrect action was taken [8]. The clinical vignette described 
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in this chapter is a combination of both types of error. The errors of commission are the blood 
bank sending the inappropriate blood to the operating room as well as the anesthesiologist 
administering the wrong blood to the patient. The failure of the blood bank to properly iden-
tify which patient was receiving the transfusion as well as the failure of the anesthesiologist to 
verify that O negative blood was sent to the operating room would be considered acts of omis-
sion. These omissions acted in conjunction with the errors of commission to result in a nearly 
disastrous outcome for the patient involved. Therefore, systems must be in place to combat 
both of these types of errors in order to keep patients safe in complex medical situations.
Secondary to human error, as many as one in 12,000 blood transfusions are administered to the 
wrong patient [1, 9, 10]. The serious hazards of transfusion (SHOT) Hemovigilance Program 
of England reports that mortality risk from transfusion in 2012 was one in 322,580 transfusion 
blood products while the morbidity rate was one in 21,000 [10, 11]. The transfusion of incorrect 
blood products, specifically ABO-incompatible blood, with resulting acute hemolytic transfu-
sion reaction is one of the most grave and yet preventable causes of transfusion-associated 
morbidity and mortality [1, 12].
Transfusion-related acute lung injury (TRALI) is another rare life-threatening adverse event that 
can present to a recipient of a blood transfusion, as was seen in our patient in the clinical vignette 
[13]. The incidence is estimated to be approximately one in 5000 transfused units with more 
recent literature citing one in 12,000 blood products [14]. However, some literature argues that 
the true incidence is unknown secondary to underdiagnosis and underreporting. Regardless, 
TRALI rates are affected by patient population with an increased occurrence observed in criti-
cally ill patients [13]. As reported by the International Haemovigilance Network, TRALI is one 
of most common etiologies behind transfusion-related fatalities. Specifically, it remains the 
leading cause in the United States [13, 14]. The study has cited TRALI-associated mortality 
ranging from 5 to 8%, but up to 50–60% in critical care patients [13]. Respiratory symptoms 
typically present within 6 h of a transfusion of any plasma-containing blood products includ-
ing intravenous immunoglobulin and cryoprecipitate [14]. TRALI is diagnosed based on clini-
cal and radiographic findings indicating new-onset acute lung injury/acute respiratory distress 
syndrome within these 6 h [13]. Majority of patients require ventilator support with oxygen 
levels returning to pre-transfusion levels in 48–96 h [14].
Currently, there are two hypothesized theories behind the pathophysiology for TRALI. The 
“two hit model” is the most widely accepted hypothesis and postulates that TRALI occurs in 
two steps [14]. The initiating event occurs pre-transfusion and is thought to be related to the 
clinical condition of the patient such as recent surgery, infection, or burns [14]. This event will 
result in the activation of the pulmonary endothelium followed by neutrophil sequestration 
to this endothelium [13–15]. The second step involves the activation of neutrophils adhered to 
this endothelium. Activation typically occurs by donor-derived antihuman leukocyte antigen 
(HLA) or antihuman neutrophil antigen antibodies targeting antigens on these surfaces (HNA) 
[14]. The activated neutrophils then incite endothelial damage which results in capillary leak 
and pulmonary edema [14, 15]. This second step is postulated to be either immune-mediated or 
non-immune-mediated. The majority of TRALI is immune-mediated, whereby neutrophil and 
HLA class I and II antibodies initiate TRALI [15]. However, approximately 15–20% of cases are 
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non-immune, whereby other biological response modifiers in the transfused blood are believed 
to be the etiology behind the reaction [14]. These factors include bioactive lipids and sCD40L 
molecules, both of which are found in stored red cell and platelet components [15]. This may 
explain why TRALI reactions can also occur in the absence of donor-derived antibodies and why 
every blood transfusion does not result in TRALI [14]. Another model known as the “threshold 
model” is believed to support cases, whereby TRALI occurs in otherwise healthy recipients who 
receive donor blood [13]. This theory postulates that if the second event is significant enough, 
then a TRALI reaction may occur without the initial clinical event [13, 14].
Given the high morbidity and mortality associated with TRALI, many preventative measures 
have been instituted in an attempt to limit these adverse transfusion reactions. These aims 
include decreasing donor-derived antibodies in blood products with elevated levels of plasma. 
This is done by obtaining blood from male donors as opposed to females with a history of 
pregnancy [14]. A history of pregnancy places these patients at an increased risk of exposure to 
anti-HLA antibodies [14]. In addition, blood donor management strategies include the inabil-
ity of patients who have had TRALI to donate whole blood or apheresis platelets [14].
With strategies in place to reduce these transfusion-related adverse events, there remains an 
additional complication to the blood transfusion process known as mistransfusion [16]. The 
SHOT program reported that nearly 30% of mistransfusions were a result of hospital labora-
tory or blood bank error [11]. These sources of error include the selection of the wrong blood 
sample for testing, inaccurate blood product labeling, technical errors, or incorrectly selected 
blood components of the wrong specification [11]. As such, an electronic pre-issuing system 
within the blood bank should be implemented to further reduce transfusion-associated mor-
bidity and mortality [11]. As a best practice, blood bank staff members should
1. print the blood order request form with patient identifier information, blood product number, 
blood type, and the name of the ordering physician;
2. prepare the blood products, print a compatibility label with a bar code, and then attach the 
label to the blood product;
3. using a handheld device, sequentially scan the bar codes and include the staff member 
identifier, the original blood product label, the newly attached bar code label, and the com-
patibility report form; and
4. ask an additional blood bank staff member to verify whether the data on the handheld scan-
ner matches the data on the labels and forms. If they do, the blood product is issued (Figure 1).
The SHOT hemovigilance scheme noted that up to 70% of transfusion errors are related to 
ABO-incompatible transfusion at the clinical bedside, with the majority of these errors attrib-
uted to a failure to properly identify the intended transfusion recipient [11, 17]. These sentinel 
events are unlikely to be caused by a single error in the transfusion process. Instead, a series 
of errors occurring together allow the opportunity for a sentinel event to occur [18]. Over the 
past decade, research has suggested moving toward an automated and computerized transfu-
sion process, with the goal of decreasing human-related error [1, 9].
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Implementation of a software-driven bar code tracking system in place of the conventional 
“nurse to nurse” double check system for the administration of blood products has been iden-
tified as a key strategy for improving transfusion safety [9]. The bar code on blood components 
identifies blood group, blood type, unit of blood, product number, and the date of collection 
[9, 10]. Several companies offer a bar code electronic identification system (EIS) which may 
be portable or built into the electronic medical system [11]. A portable handheld scan and 
print electronic device can be used to verify and document patient identity. Such a device is 
utilized at our institution [11]. The common components of the pre-transfusion check list to 
be scanned include the patient name, medical record number, and blood group [11]. If the bar 
codes between the patient wristband and blood products match, then the handheld device 
indicates as such [11]. The bar code EIS is linked to a network host computer that can store, 
search, and send transfusion data [11]. Multiple studies have indicated that the electronic bar 
code system is effective in reducing human error related to transfusion procedures as it acts 
as another barrier for error in the transfusion process [10]. In a time-sensitive event such as 
a massive transfusion protocol, safety checks including barcoding EIS may be omitted. This 
may reintroduce transfusion-related human error, such as incorrect blood product adminis-
tration to the recipient.
Current research is exploring the use of smartphone or tablet devices in transfusion medicine 
with the aim of achieving enhanced integrity of the transfusion process [10]. In addition, 
systems utilizing radiofrequency identification (RFID) are being analyzed as a new way of 
integrating technology into blood transfusion best practice. However, high costs for an insti-
tution can be a barrier [10, 11]. RFID is a more user-friendly technology and can be applied to 
improve visual and bar code electronic identification systems [11, 16]. Radiofrequency tran-
sponder microchips have been utilized on patient wristbands, blood sample tube labels, and 
Figure 1. Serious hazards of transfusion (SHOT) best practice flowchart.
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blood product containers [1, 16]. The microchips are scanned by a handheld portable device 
and uploaded to a program with the operator alerted to a misstep and the program pausing 
until the error is corrected [16]. RFID can be used to further standardize and monitor blood 
collection, preparation, and transfusion in order to reduce transfusion-related human error 
and improve patient safety [16].
4. The operational aspects of EBT
The operational aspects of EBT present many challenges that can be overcome by planning 
and employing best practices. These challenges include describing how to recognize, initi-
ate, and alert others to an EBT. A hospital system must also decide on what kind of blood 
products to store and how to prioritize select products when they are in high demand. In 
addition, determining where to store blood products and deciding how to transport them to 
the bedside require careful planning, especially when faced with multiple concurrent patients 
requiring EBTs. Personnel should also be trained on how to resuscitate patients while waiting 
for the arrival of blood products.
The first step in any EBT starts with the attending provider recognizing the need to transfuse. 
Common indications for EBT include an elevated Assessment of Blood Consumption (ABC) 
score, the presence of visible rapid blood loss such as that seen in postpartum hemorrhage, 
or the observation of even moderate blood loss in the setting of comorbidities such as low 
cardiopulmonary reserve. This list is not exhaustive. The ABC score is calculated by assigning 
a score of one to each parameter present: penetrating injury, positive focused assessment 
sonography for trauma (FAST), systolic blood pressure of 90 mm Hg or less, and an elevated 
heart rate of at least 120 beats per minute (Table 1). An ABC score of 2 or higher is 75% sensi-
tive and 86% specific for predicting the need for massive transfusion (MT) [19].
After recognizing the need for transfusion, the second step in an EBT is to alert the blood 
bank. Our institution offers two levels of response to an EBT: emergency blood release (EBR) 
and an elevated response level of “code crimson” (CC). Either is initiated by a medical pro-
vider dialing a simple hotline—“5555” at our institution—that is answered immediately by 
the emergency operator. Notification of an EBR arrives in the blood bank via an alphanumeric 
Criteria
Penetrating Mechanism No 0 Yes + 1
ED Systolic BP ≤ 90 mmHg No 0 Yes + 1
ED HR ≥ 120 No 0 Yes + 1
Positive Ultrasound FAST Exam No 0 Yes + 1
ED, emergency department; BP, blood pressure; HR, heart rate; FAST, focused assessment with sonography in trauma.
Table 1. Assessment of blood consumption score.
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pager alert. By contrast, a CC is initiated by an overhead announcement broadcast through-
out the hospital, alerting support personnel from anesthesia, surgery, trauma, intensive care, 
and emergency medicine to move toward assisting resuscitation of the patient. Either level 
of response can be initiated by pre-hospital professionals such as paramedics, transporting a 
hemorrhaging trauma patient.
Selecting which blood products to offer is an important decision made well before an alert is initi-
ated. While regional blood bank centers can effectively offer continuous availability and supply 
of blood products to local hospitals—even at times of disaster [20]—there may be occasions when 
the hospital runs low on specific products, such as platelets or Rhesus negative blood. With only a 
small minority of the US population exhibiting an O negative blood group, the finite supply of O 
negative blood may dwindle in the face of ongoing massive transfusion. Switching to O positive 
blood reserves a minimal supply of emergency O negative blood for obstetric patients or other 
women of reproductive age who may need blood before depleted stocks can be replenished. 
This forethought helps prevent alloimmunization-associated problems in future pregnancies 
[21]. Aside from O negative blood, another scarce blood product is platelets. Though they can be 
used for up to 5 days after collection, the effective life of a pack of platelets is just 1–2 days by the 
time the collection is processed, tested, packaged, and transported from the regional blood bank 
to the hospital. Hospital blood banks can now take advantage of the Platelet PGD test (Verax 
Biomedical, Marlborough, MA) approved by the FDA in 2015 to extend the life of platelets by an 
additional 2 days, dramatically reducing the waste and expense of these products.
Once an EBT is initiated, the next consideration at some institutions is to determine which 
blood bank will respond. Close proximity to blood products is desirable, though not univer-
sally feasible. Many hospitals in America feature several hundred beds [22] that are spread 
across medical, surgical, obstetric, operative, intensive care, emergency, and trauma areas. 
A large campus with many buildings may have satellite blood stores. Attempts to minimize 
time and distance to blood products via the setup of decentralized blood refrigeration units 
add cost, complexity, and forgoes the expertise offered by specialized blood banking person-
nel during the early stages of an emergency transfusion.
After the appropriate blood bank has been alerted, the transport of emergency blood products 
to the patient requires a transport protocol. At our institution’s centralized blood bank, an 
EBR utilizes a pneumatic tubing system (PTS) to move a maximum of two units of ice-packed 
erythrocytes, whereas a CC uses a human transporter—a “runner”—with a cooler. The cooler 
contains six units of iced erythrocytes, four units of thawed fresh-frozen plasma, and a single 
unit of platelets. Subsequent coolers are prepared regularly until the CC is terminated. The 
number of runners and their speed is the limiting factor in bringing blood to the patient, 
not the rate of cooler preparation. A PTS is faster than a runner [23], moving at up to 25 feet 
per second, often taking a route that is more direct than what is achievable by hallways and 
stairwells. PTS performance can be further enhanced with priority signaling or the use of 
dedicated tubing channels to patient areas that frequently require EBT, such as the emergency 
department.
Though advantageous in some ways, the PTS also has disadvantages. The dimensions and 
weight capacity of PTS containers can be limiting, with six containers needed to carry the cargo 
of a single cooler. Though rare, leaking blood product packaging can seep into the container. 
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If the seal of a poorly maintained container is compromised, the leak can enter into the system 
tubing. Cleanup of a contaminated PTS system is a non-trivial task. Another limitation of PTS 
containers is that they arrive only in the vicinity of the patient and still require a runner for final 
transport to the bedside. A final concern with a PTS is that once a container enters the tubing 
system, the acceleration and speed of the system exerts at least some hemolytic effect [23].
In concurrent emergency transport of blood products for two or more patients, separate pneu-
matic tube containers or separate runners must be used to carry blood products for each 
patient. Runners should be instructed to avoid exchanges along their route to the patient. The 
requirement of a unique runner for each patient can be challenging to meet during off-peak 
times when staffing levels are reduced.
During the interval between recognition for the need of EBT and the arrival of blood products, 
medical personnel should work to prepare the patient for transfusion. The airway needs to 
be assessed and protected. Vital signs should be measured. If possible, an attempt should be 
made to correct the underlying etiology of the hemorrhage. Tourniquets should be applied 
to the bleeding wounds of trauma patients, packing should be used to tamponade bleed-
ing surgical patients, and uterotonic agents should be administered in cases of postpartum 
hemorrhage. A blood sample should be collected to facilitate a type and cross-match, though 
providers should expect at least a 45-min wait time for the screen to be completed. Large 
bore needles should be inserted to establish intravenous access. A baseline set of hemo-
globin, platelets, electrolytes including calcium, a calculated anion gap, creatinine, lactate, 
prothrombin time, partial thromboplastin time, and fibrinogen level should be drawn [21]. 
The patient should be warmed to help stop the development of a coagulopathy. Depending 
on the clinical situation, volume resuscitation using intravenous fluid boluses may be judi-
ciously used. The infusion of a crystalloid may dilute the remaining platelets and coagulation 
factors as well as cause hypothermia.
The next step in an EBT lies in the administration of emergency blood products from the 
responding blood bank. Two different patient identifiers, such as hospital identification num-
ber and patient name, should be used by medical personnel to confirm the patient identiy [24].
While many different transfusion protocols exist, warmed erythrocytes, fresh-frozen plasma, 
and platelets are commonly transfused at a 1:1:1 ratio. Some centers have added 6–10 units of 
cryoprecipitate to their MBT practice to aid repletion of low fibrinogen levels [25]. However, 
there is a lack of high-quality randomized trials to show improved outcomes with the use 
of cryoprecipitate to raise fibrinogen levels [26]. The FDA’s approval of the human fibrino-
gen concentrate drug RiaSTAP (CSL Behring, King of Prussia, PA) has been investigated 
in the off-label setting of MTP [27]. A second similar drug—Fibryna (Octapharma, Lachen, 
Switzerland)—was approved by the FDA in 2017. Further clinical trials are needed to estab-
lish whether human fibrinogen concentrates improve outcomes in severe hemorrhage featur-
ing hypofibrinogenemia.
Irrespective of the products transfused, the rate of infusion is a prime concern. Rapid infusers such 
as the RI-2 (Belmont Instruments, Billerica, MA) inductively warm and infuse blood at selectable 
rates of up to 1000 mL/min. This speed can surpass the loss in a postpartum hemorrhage patient, 
in whom at term blood perfuses the placental site at a rate of 500–700 mL per minute [25].
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In addition to the use of fibrinogen-rich medications or cryoprecipitate, anti-fibrinolytics also 
play a role in EBT. Tranexamic acid can safely reduce the risk of death in both trauma and 
obstetric-related hemorrhage [28, 29]. The drug must be administered within 3 h of bleeding 
onset. It is associated with a minimal adverse event rate [28].
Different solutions exist for bleeding while anticoagulated on warfarin. The prothrombin 
complex concentrate drug Kcentra (CSL Behring, King of Prussia, PA) can reverse coagula-
tion factor deficiency induced by a vitamin K antagonist faster than fresh-frozen plasma [30].
Determining when to stop transfusing can also be challenging. An i-Stat device (Abbott Point 
of Care Inc., Princeton, NJ, USA) should be avoided if possible [31]. Evaluating the response 
to transfusion can be achieved via a serum hemoglobin value 15 min after transfusion. Other 
reassuring laboratory values include a platelet count greater than 50,000/μL, an international 
normalized ratio (INR) of less than 1.5, or a fibrinogen level greater than 100 mg/dL. Ultimately, 
the normalization of the patient’s hemodynamic status in conjunction with visible signs of 
hemostasis should signal the medical provider to terminate the code crimson. Alternatively, 
the recognition of the futility of resuscitation should also be viewed as a terminal end point. 
Upon termination of the blood transfusion, unused blood products should be returned to the 
blood bank for refrigeration and storage. The blood products transported by runners or the PTS 
are continuously monitored thermally to ensure the integrity of returned, unused products.
5. Benefits of emergency blood transfusion protocols
EBT protocols facilitate the efficient ordering and transport of blood products for patients 
with moderate to severe hemorrhage. These protocols also ensure that an ongoing supply 
of blood products arrives at the patient’s bedside until hemostatic control is achieved. Many 
hospitals have established an MTP. In obstetrics, 95% of hospitals with a postpartum hemor-
rhage protocol possess an MTP [32]. An MTP is traditionally defined as more than 10 units of 
pRBCs in 24 h or more than four units of pRBCs in 1 h.
An MTP can be used to manage severe maternal hemorrhage and improve patient safety. In 
their study, Shields et al. showed a faster resolution of maternal bleeding, the use of fewer 
blood products, and a 60% decline in the rate of DIC with the use of MTP [33]. In addition, the 
establishment of an MTP protocol led to both physicians and nursing staff reporting improved 
clinical knowledge and comfort level with responding to significant bleeding events.
Health-care providers have varying experience levels in dealing with EBT and MBT. The rela-
tively low frequency with which MBT is encountered limits the accumulation of experience 
with severe hemorrhage. This suggests that standardized interventions are critical in order to 
achieve an optimal outcome. One way to gain experience and familiarity with standardized 
EBT protocols is through simulation.
6. Benefits of simulation
Simulation is used to train and familiarize providers with how to respond to emergency situ-
ations. By using team approaches to problem solving and utilizing root cause analysis, patient 
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outcomes can be continuously improved [34]. Such methods are highlighted in the Joint 
Commission Sentinel Alert publication that recommends the adoption of protocols to address, 
for example, morbidity and mortality associated with maternal hemorrhage [35].
There are many advantages to developing high-fidelity simulations. They include establishing a 
safe environment for patients and trainees, the opportunity for multidisciplinary team training, 
and the rehearsal of specific behavioral skills. In addition, simulations allow the difficulty levels 
of scenarios to escalate, providing multiple exposures to complex clinical scenarios. Simulators 
also allow the testing and learning of new technologies without exposing the patients to learn-
ing-associated risk [36]. High-fidelity simulators also allow individuals to train on demand 
rather than waiting for an uncommon or very specific situation to occur. Simulations allow for 
pause, discussion, feedback, and reflection in response to certain circumstances, as well as the 
opportunity to identify and correct recurrent mistakes in an expedited manner [37].
7. Error tracking systems
Though uncommon, transfusion-associated adverse events can occur in the emergency set-
ting. In response, programs have been established that track these events. The goals of these 
programs are to ultimately improve patient safety by minimizing the morbidity and mortal-
ity of transfusion procedures. The programs also serve to identify emerging complications, 
including errors and near misses, as well as pathogens associated with blood transfusion. One 
such surveillance protocol is the National Healthcare Safety Network Biovigilance Component 
Hemovigilance (NHSN HV) module [38]. This module can be used by any US health-care 
facility where blood components and products are transfused. Participation requires a 
comprehensive surveillance of patients and blood components throughout the transfusion 
process, from product receipt until patient administration. In addition, the reporting of all 
adverse transfusion reactions and associated incidents that occur for patients transfused at 
the studied facility is required. By participating in the module, health-care facilities can use 
data entered into the National Healthcare Safety Network to monitor adverse reactions and 
events. This allows for better identification of areas requiring intervention and to modify pre-
vention strategies that reflect the specific needs of a particular health-care facility.
8. St. Luke’s University Health Network: blood transfusion 
information
Like other tertiary-care centers, our hospital system has implemented an MTP designated as 
“code crimson” to facilitate the rapid availability of blood products when persistent hemody-
namic instability occurs in a patient, among other indications. In line with our institution’s initia-
tive for continuous quality improvement, departmental risk assessments and safety management 
plans have been enacted. This program requires managers of departments with unique risks to 
assess their department’s risk profile and submit a summary of safety guidelines to the safety 
and security manager of their campus. This call for ongoing quality improvement allows for 
brainstorming sessions with physicians and staff to identify risk and to determine the methods, 
equipment, policies, and training that can be used to manage and mitigate such risks.




Emergency blood transfusion remains a clinical challenge, occasionally marked by improper 
transfusion of incompatible blood that leads to severe patient morbidity and mortality. Through 
this hypothetical case scenario, we have highlighted the risks of improper transfusion and dis-
cussed improvements in patient safety during emergency transfusion, including developing best 
practice models, integrating new technologies, as well as improvements in operational aspects 
via simulation and error tracking systems. By further investing in protocols and systems that 
enhance safeguards in transfusion medicine, we can continue to strive toward the elimination 
of transfusion errors and their sequelae. Ongoing research, continuous intensive analysis, and 
quality improvement initiatives are needed for further advancement of transfusion safety.
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